Among patients with myeloproliferative neoplasms, men with primary myelofibrosis diagnosed after 2006 are at the highest risk of developing secondary acute myeloid leukemia (AML).
ASCO has laid out a game plan to set the stage for incorporating new therapies and approaches into clinical guidelines as quickly and accurately as possible.
Researchers found tracking symptoms and alerting doctors to problems early led to longer survival for patients with lung cancer.
ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.
Three in four of young or middle-aged patients with terminal cancer receive aggressive therapies in their last months of life.
The American Society for Clinical Oncology has developed guidelines for the management and palliative care of women diagnosed with invasive cervical cancer.
ASCO Statement Seeks to Balance Prescription Opioids for Patients With Cancer and Misuse and Abuse PreventionMay 31, 2016
ASCO addresses the complex issues surrounding prescription opioids in a new policy statement. ASCO supports the efforts of multiple federal offices and agencies to prevent and respond to prescription drug abuse, and is also working to protect access to appropriate medical opioid therapy for patients with cancer.
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
Guideline on muscle-invasive and metastatic bladder cancer, with qualifying statements
A new clinical practice guideline on the appropriate use of tests for breast tumor biomarkers was issued by ASCO.
Qualifications to guidelines include stronger statements in favor of chemotherapy in some cases.
Treating advanced melanoma patients with either a combination of nivolumab and ipilimumab, or nivolumab alone, significantly increases progression-free survival (PFS) when compared with ipilimumab alone.
Survival gains observed when elotuzumab was added to treatment.
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.
For some patients with advanced melanoma, surgical removal of the lymph nodes surrounding their tumor may not be needed.
Fewer side effects, longer survival for nivolumab versus docetaxel seen in patients with non-small-cell lung cancer (NSCLC).
Significant clinical variations have been identified among patients with hepatocellular carcinoma (HCC).
A preliminary Australian study saw association between nicotinamide and lower rates of non-melanoma skin cancers.
Researchers report 3 percent annual rise in intermediate- and high-risk cases
When active surveillance is chosen, survival for intermediate-risk disease may be decreased.
Individuals who've had testicular cancer may be at increased risk for prostate cancer, but the overall risk is low, according to a study.
Guideline outlines recommended follow-up care for prostate cancer survivors
Certain types of cancer patients tended to have lower vitamin D levels
The endorsed guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.
A majority of of palliative care clinicians report burnout, according to a study, with the greatest risk of burnout for younger clinicians and those working more than 50 hours per week
Most patients use lifestyle-altering strategies and about 40 percent adopt a care-altering strategy to manage financial distress associated with their cancer care.
Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.
A new immunotherapy vaccine candidate for breast cancer shows promise, having reduced recurrence rate by more than fifty percent.
Recommendations are for men whose tumors have grown resistant to hormonal therapies were issued jointly by the American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) in Canada.
Women overdue for mammogram respond better to postcard plus reminder letter from family physician.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Targeting AR Mutations Promising in Metastatic Prostate Cancer
- GUCS 2017: Early Immunotherapy Discontinuation in mRCC
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|